SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023926
Filing Date
2022-11-09
Accepted
2022-11-09 16:31:44
Documents
75
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eras-20220930.htm   iXBRL 10-Q 3258237
2 EX-31.1 eras-ex31_1.htm EX-31.1 18859
3 EX-31.2 eras-ex31_2.htm EX-31.2 18874
4 EX-32.1 eras-ex32_1.htm EX-32.1 10470
5 EX-32.2 eras-ex32_2.htm EX-32.2 10801
6 GRAPHIC img197769362_0.jpg GRAPHIC 87329
  Complete submission text file 0000950170-22-023926.txt   11799211

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eras-20220930_cal.xml EX-101.CAL 44566
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eras-20220930.xsd EX-101.SCH 64506
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eras-20220930_def.xml EX-101.DEF 274978
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eras-20220930_lab.xml EX-101.LAB 532171
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eras-20220930_pre.xml EX-101.PRE 399761
69 EXTRACTED XBRL INSTANCE DOCUMENT eras-20220930_htm.xml XML 2395549
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

IRS No.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40602 | Film No.: 221373190
SIC: 2834 Pharmaceutical Preparations